Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?

The management of locally advanced rectal cancer (LARC) requires multimodality treatment, typically with neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision. However, the treatment landscape is rapidly evolving with total neoadjuvant therapy and non-operative management for sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Piercey, Oliver, Tie, Jeanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Liquid Biopsy in Gastrointestinal Cancers: circulating tumor DNA (ctDNA) and circulating tumor cell (CTC)-based precision oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017954/
https://www.ncbi.nlm.nih.gov/pubmed/36936200
http://dx.doi.org/10.1177/17588359231160138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017954/
https://www.ncbi.nlm.nih.gov/pubmed/36936200
http://dx.doi.org/10.1177/17588359231160138

Ejemplares similares